Catheter radiofrequency ablation in atrial fibrillation and flutter management in patients with comorbidities

Kachanova Yu.A.; Marfunina A.A.; Novikova N.A.; Syrkin A.L.

doi:https://doi.org/10.17116/kardio20169446-50

Kachanova Yu.A.

Sechenov First Moscow State Medical University, Moscow

Marfunina A.A.

«City Clinical Hospital №4» of Moscow Department of Health, Moscow, Russia

Novikova N.A.

Pervyĭ MGMU im. I.M. Sechenova, klinika kardiologii

Syrkin A.L.

Sechenov First Moscow State Medical University

Scopus AuthorID: 7103104759
ORCID: 0000-0002-9602-292X

Catheter radiofrequency ablation in atrial fibrillation and flutter management in patients with comorbidities

Authors:

Kachanova Yu.A., Marfunina A.A., Novikova N.A., Syrkin A.L.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2016;9(4): 46‑50

DOI: 10.17116/kardio20169446-50

Read: 4852 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Kachanova YuA, Marfunina AA, Novikova NA, Syrkin AL. Catheter radiofrequency ablation in atrial fibrillation and flutter management in patients with comorbidities. Russian Journal of Cardiology and Cardiovascular Surgery. 2016;9(4):46‑50. (In Russ.)
https://doi.org/10.17116/kardio20169446-50

Подписка 2026 Кардиология и сердечно-сосудистая хирургия (Russian Journal of Cardiology and Cardiovascular Surgery)

Использование инфографики авторами научных работ

References:

Аleksandrov А.А., YAdrikhinskaya M. N., Аbdalkina E.N., Kukharenko S.S., SHatskaya O.А. Atrial fibrillation and diabetes mellitus: prevention therapy. Lechashhij vrach. 2013;5:24-28. (in Russian)
Foldesi C, Pandozi C, Peichl P, Bulava A, Castro A, Lamberti F, Calo L, Loricchio ML, Santini M. Atrialflutter: arrhythmia circuit and basis for radiofrequency catheter ablation. Ital Heart J. 2003;4:395-403.
Аrdashev А.V., Аntonchenko I.V., Аrdashev V.N. Klinicheskaya aritmologiya. M.: ID Medpraktika-M. 2009;1220.(in Russian)
Аrdashev А.V., ZHelyakov E.G., SHavarov А.А. Typical atrial flutter: classification, clinical manifestations, diagnosis and treatment. Kardiologiya. 2010;4:57-65.(in Russian)
CHazov E.I., Golitsyn S.P. Rukovodstvo po narusheniyam ritma serdtsa. 2010;157. (in Russian)
Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol. 2006;48:e149-e246.
Klem I, Wehinger C, Schneider B, et al. Diabetic atrial fibrillation patients: mortality and risk for stroke or embolism during a 10-year follow-up. Diabetes Metab Res Rev. 2003;19:320-328.
Singh BN, Singh SN, Reda DJ, et al. Amiodarone versussotalolfor atrial fibrillation. N Engl J Med. 2005;352:1861-1872.
Dublin S, Glazer NL, Smith NL, Psaty BM, Lumley T, Wiggins KL, Page R.L., Heckbert SR. Diabetes mellitus, glycemic control, and risk of atrial fibrillation. J Gen Intern Med. 2010 Aug;25(8):853-858.
Movahed MR, Hashemzadeh M, Jamal MM. Diabetes mellitus is a strong, independentrisk for atrial fibrillation and flutter in additiontoothercardiovascular disease. Int J Cardiol. 2005 Dec 7;105(3):315-318.
Migra M, Kovař F, Mokaň M. Thearrhytmiasin patients withdiabetes mellitus. Article in Slovak Vnitr Lek. 2013 May;59(5):361-365.
Lin Y, Li H, Lan X, Chen X, Zhang A, Li Z. Mechanism of and therapeutic strategy for atrialfibrillationassociated withdiabetes mellitus. Scientific World Journal. 2013;209-428. doi: 10.1155/2013/209428
Negishi K, Seicean S, Negishi T, Yingchoncharoen T, Aljaroudi W, Marwick TH. Relation of heart-rate recovery to new onset heart failure and atrialfibrillationin patients withdiabetes mellitusand preserved ejection fraction. Am J Cardiol. 2013 Mar 1;111(5):748-753. doi: 10.1016/j.amjcard.2012.11.028
Kejko O.I., Gerok D.V., Gilyarov M.YU., Novikova N.А., Sedov V.P. Clinical and echocardiographic predictors of atrial fibrillation and flutter recurrence after electrical cardioversion. Vestnik aritmologii. 2011; 63-67.(in Russian)
Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation. 2007;115:3213-3223.
Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007;115:387-397.
Morgunov L.YU. Cardiac arrhythmias in patients with diabetes mellitus type 2. Praktikuyushhij vrach. 2013;120-125.(in Russian)
Waldo AL, Allessie MA, Boyden PA, Camm AJ, Kleber AG, Lab MJ, Legato MJ, Rosen MR, Schwartz PJ, Spooner PM, Van Wagoner DR. Pathophysiology and prevention of atrial fibrillation. Circulation. 2001 Feb 6;103(5):769-777.
Bojtsov S.А. Mertsatel'naya aritmiya. SPb. 2001;8-16; 86, 87; 211-238.(in Russian)
Egorov D.F., Leshhinskij L.А., Nedostup А.V., Tyul'kina E.E. Atrial fibrillation. Strategy and tactics of treatment at the threshold of the twenty-first century. SPb -Izhevsk-M. 1998;155-176;235-236. (in Russian)
Istomina T.А., GovshaYU.А., Voronin I.M. i dr. The role of high-quality electrocardiography in assessing the effectiveness of anti-arrhythmic drugs class IA and III in patients with paroxysmal atrial fibrillation-flutter. Kardiologiya. 1999;11:31-33.(in Russian)
Nedostup А.V., Аlekseevskaya M.А., Novikov I.D. i dr. Comparison of the effectiveness of quinidine and cordarone as the medicines for stabilizing of restored sinus rhythm in patients with persistent atrial fibrillation. Terapevticheskij arkhiv. 1990;9:47-50.(in Russian)
Perunova E.R.,i dr. Experience of conservative treatment of atrial flutter. Samarskij meditsinskij zhurnal. 2003;2:75- 77.(in Russian)
Kushakovskij M.S. Аritmii serdtsa. Rukovodstvo dlya vrachej. SPb.: Izd-vo Gippokrat. 1992;63-64.(in Russian)
Glezer M.G., Orlov L.L., Titova D.KH., Sobolev K.EH. Changes of central hemodynamic parameters with isometric exercise in elderly patients with circulatory failure of various stages. Klinicheskaya gerontologiya. 1995;1:23-26. (in Russian)
Primeau R, Agha A, Giorgi C, Shenasa M, Nadeau R. Long-term efficacy and toxicity of amiodarone in the treatment of refractory cardiac arrhythmias. Can J Cardiol. 1989 Mar;5(2):98-104.
Waldo AL, Geller JC, Geller M, Carlson MD. Efficacy and safety ofmoricizinein the maintenance of sinus rhythm in patients with recurrent atrial fibrillation. Am J Cardiol. 2001 Jan 15;87(2):172-177.
Nedostup А.V., Blagova O.V. Kak lechit' aritmii. M.: Izd-vo MEDpress-inform. 2008;105-107.(in Russian)
Wilber DJ, Baerman J, Olshansky B, et al. Adenosine sensitive ventricular tachycardia: clinical characteristics and response to catheter ablation. Circulation. 1993;126-134.
Klinicheskie rekomendatsii po provedeniyu ehlektrofiziologicheskikh issledovanij, kateternoj ablyatsiii, primeneniyu implantiruemykh antiaritmicheskikh ustrojstv. Vserossijskoe nauchnoe obshhestvo spetsialistov po klinicheskoj ehlektrofiziologii, aritmologiii kardiostimulyatsii (VNOА). M. 2011;518. (in Russian)
ACC/AHA/ESC Guidelines for the management of patients with supraventricular arrhythmias - executive summary. J Am Coll Cardiol. 2003;42(8):493-531.
Blomstrom-Lundqvist C, Scheinman MM, Aliot EMC. Сonsensus guidelines for SVT management. Circulation. 2003;108:1871-1909.
Perce MA. The CK Isoenzymes: Findings and their meaning. Lab Management. 1982;20:2537.
Perry J. Supraventricular tachycardia due to Wolff-Parkinson- White syndrome in children: Early disappearance and late recurrence. Coll Cardiol. 1990;16:1215-1220.
Huang S. Radiofrequency catheter ablation of the left and right ventricles: anatomic and electrophysiologic observations. PASE. 1998;11:449-459.
Zimmerman J. Diagnostic marker cooperative study for the diagnosis of myocardial infarction. Circulation. 1999;99:1671-1677.
LaPointe NM. In-hospital management of patients with atrial flutter. Am Heart J. 2010 Mar;159(3):370-376.
Hottigoudar RU, Deam AG, Birks EJ, McCants KC, Slaughter MS, Gopinathannair R. Catheter ablation of atrial flutter in patients with left ventricular assist device improves symptoms of right heart failure. Congest Heart Fail. 2013 Jul;19(4):165-171. doi: 10.1111/chf.12034
Anselmino M, Grossi S, Scaglione M, Castagno D, Bianchi F, Senatore G, Matta M, Casolati D, Ferraris F, Cristoforetti Y, Negro A, Gaita F. Long-term results of transcatheter atrial fibrillation ablation in patients with impaired left ventricular systolic function. J Cardiovasc Electrophysiol. 2013 Jan;24(1):24-32. Doi: 10.1111/j.1540-8167.2012.02419.x
Bamimore A, Mounsey P. Ablation of atrial tachycardia and atrial flutter in heart failure. Heart Fail Clin. 2013 Oct;9(4):501-514. doi: 10.1016/j.hfc.2013.07.002
Cai L, Yin Y, Ling Z, Su L, Liu Z, Wu J, Du H, Lan X, Fan J, Chen W, Xu Y, Zhou P, Zhu J, Zrenner B. Predictors of late recurrence of atrialfibrillationafter catheter ablation. Int J Cardiol. 2013 Mar 20;164(1):82-87. doi: 10.1016/j.ijcard.2011.06.094
Brembilla-Perrot B, Huttin O, Manenti V, Benichou M, Sellal JM, Zinzius PY, Beurrier D, Schwartz J, Laporte F, de Chillou C, Andronache M, Cismaru G, Pauriah M, Selton O, Louis P, Terrier de la Chaise A. Sex-related differences inperi- and post-ablation clinical data for patients with atrial flutter. Int J Cardiol. 2013 Jan 22. pii: S0167-5273(12)01732-9 doi: 10.1016/j.ijcard.2012.12.088
Hayashi T, Fukamizu S, Hojo R, Komiyama K, Tanabe Y, Tejima T, Nishizaki M, Hiraoka M, Ako J, Momomura SI, Sakurada H. Prevalence and electrophysiological characteristics of typical atrial flutter in patients with atrial fibrillation and chronic obstructive pulmonary disease. Europace. 2013 Jun 19.
Naruse Y, Tada H, Sekiguchi Y, Machino T, Ozawa M, Yamasaki H, Igarashi M, Kuroki K, Itoh Y, Murakoshi N, Yamaguchi I, Aonuma K. Concomitant chronic kidney disease increases the recurrence of atrial fibrillation after catheter ablation of atrial fibrillation: a mid-term follow-up. Heart Rhythm. 2011 Mar;8(3):335-341. Doi: 10.1016/j.hrthm.2010.10.047
Lakkireddy D, Nagarajan D, DiBiase L, Vanga SR, Mahapatra S, Jared Bunch T, Day JD, Burkhardt DJ, Umbarger L, Dendi R, Pimentel R, Berenbom L, Emert M, Gerken A, Bommana S, Ray W, Atkins D, Murray C, Dawn B, Natale A. Radiofrequency ablation of atrial fibrillation in patients with mitral or aortic mechanical prosthetic valves: a feasibility, safety, and efficacy study. Heart Rhythm. 2011 Jul;8(7):975-980. doi: 10.1016/j.hrthm.2011.02.012
Santangeli P, DiBiase L, Bai R, Horton R, Burkhardt JD, Sanchez J, Price J, Natale A. Advances in catheter ablation: atrial fibrillation ablation in patients with mitral mechanical prosthetic valve. Curr Cardiol Rev. 2012 Nov;8(4):362-367.
Bradfield J, Shapiro S, Finch W, Tung R, Boyle NG, Buch E, Mathuria N, Mandapati R, Shivkumar K, Bersohn M.Catheter ablation of typical atrial flutter in severe pulmonary hypertension. J Cardiovasc Electrophysiol. 2012 Nov;23(11):1185-1190. doi: 10.1111/j.1540-8167.2012.02387.x
Tomson TT, Kapa S, Bala R, Riley MP, Lin D, Epstein AE, Deo R, Dixit S. Risk of stroke and atrial fibrillation after radiofrequency catheter ablation of typical atrial flutter. Heart Rhythm. 2012 Nov;9(11):1779-1784. Doi: 10.1016/j.hrthm.2012.07.013
Tang RB, Dong JZ, Liu XP, Fang DP, Longde Y, Liu XH, Yu RH, Hu FL, Lu CS, Hao P, Kalifa J, Ma CS. Safety and efficacy of catheter ablation of atrial fibrillation in patients with diabetes mellitus-single center experience. J Interv Card Electrophysiol. 2006 Oct;17(1):41-46.